首页> 外文会议>Conference on diagnostic and therapeutic cardiovascular interventions >Excimer laser coronary angioplasty: clinical results and future directions
【24h】

Excimer laser coronary angioplasty: clinical results and future directions

机译:准分子激光冠状动脉成形术:临床结果和未来方向

获取原文

摘要

Abstract: Despite four years of intensive clinical investigation, excimer laser coronary angioplasty has not been accepted by the interventional cardiology community as the intervention of choice for any lesion type. Although the preliminary analysis presented here shows that the new technology shows promise for the treatment of saphenous vein graft lesions, aorto-ostial lesions and other lesions, these lesion types account for only about 5 - 10% of cases currently targeted for angioplasty and can frequently be treated with other interventional methods. Broader use of excimer laser angioplasty requires convincing proof that the new technology has clear superiority over other interventional techniques for a wider range of lesion types. Furthermore, the mechanisms of vessel dissection, perforation and abrupt closure need further clarification. Thus, the major challenges for excimer laser angioplasty include: (1) randomized trials to document the superiority of excimer laser over balloon angioplasty; (2) improved catheter designs, including devices for eccentric lesions and total occlusions; and (3) a better understanding of laser-tissue interactions to reduce the unpredictability of unfavorable angiographic outcome. !14
机译:摘要:尽管经过四年的深入临床研究,但准分子激光冠状动脉成形术尚未被介入心脏病学界接受为任何病变类型的首选介入治疗方法。尽管此处介绍的初步分析表明该新技术显示出了治疗大隐静脉移植物病变,主动脉口病变和其他病变的前景,但这些病变类型仅占目前血管成形术靶向病例的约5-10%,并且可以频繁发生用其他介入方法治疗。准分子激光血管成形术的广泛使用需要令人信服的证据证明,对于更广泛的病变类型,新技术比其他介入技术具有明显的优势。此外,血管解剖,穿孔和突然闭合的机制需要进一步阐明。因此,准分子激光血管成形术的主要挑战包括:(1)随机试验证明准分子激光优于球囊血管成形术; (2)改进导管设计,包括偏心病变和完全闭塞的装置; (3)更好地了解激光与组织的相互作用,以减少不良血管造影结果的不可预测性。 !14

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号